Trials / Conditions / Patent Ductus Arteriosus After Premature Birth

Patent Ductus Arteriosus After Premature Birth

12 registered clinical trials studyying Patent Ductus Arteriosus After Premature Birth — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Completed	Prophylactic IV Paracetamol in Extremely Premature Infants NCT07067177	Al-Quds University	Phase 2 / Phase 3
Recruiting	Co-administration of Acetaminophen With Ibuprofen to Improve Duct-Related Outcomes in Extremely Premature Infa NCT05340582	Mount Sinai Hospital, Canada	Phase 2
Unknown	Hemodynamically Important Patent Ductus Arteriosus in Newborns Under 32 Weeks NCT05686343	Ankara University	—
Unknown	PDA Treatment With Ibuprofen and Changes in Tissue Oxygenation. NCT05325177	Ottawa Hospital Research Institute	Phase 4
Recruiting	Selective Early Medical Treatment of Patent Ductus Arteriosus in Extremely Low Gestational Age Infants: A Pilo NCT05011149	IWK Health Centre	Phase 3
Completed	Oral Ibuprofen Versus Placebo in Treatment of Patent Ductus Arteriosus (PDA)in Preterm Infants NCT05493540	Nada Youssef	Phase 2
Unknown	Combined Lung Ultrasounds and Transthoracic Electrical Bioimpedance in Preterm Infants With Respiratory Distre NCT04359134	IRCCS Azienda Ospedaliero-Universitaria di Bologna	—
Withdrawn	Indomethacin PK-PD in Extremely Preterm Neonates NCT04025177	University of Manitoba	Phase 2
Completed	Timing of Surgical PDA Ligation and Neonatal Outcomes NCT04126512	IRCCS Azienda Ospedaliero-Universitaria di Bologna	—
Active Not Recruiting	Management of the PDA Trial NCT03456336	NICHD Neonatal Research Network	Phase 3
Unknown	The Effects of Phototherapy in Preterm Infants Pda NCT03675425	Zekai Tahir Burak Women's Health Research and Education Hospital	N/A
Completed	Paracetamol Versus Ibuprofen in Premature Infants With Hemodynamically Significant Patent Ductus Arteriosus NCT04037514	Máximo Vento Torres	Phase 3